AnaptysBio Inc (NASDAQ: ANAB) is -3.49% lower on its value in year-to-date trading and has touched a low of $12.21 and a high of $41.31 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ANAB stock was last observed hovering at around $23.88 in the last trading session, with the day’s loss setting it -0.13%.
Currently trading at $23.75, the stock is 2.30% and 8.94% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.21 million and changing -0.54% at the moment leaves the stock 10.24% off its SMA200. ANAB registered 79.38% gain for a year compared to 6-month gain of 79.65%.
The stock witnessed a 0.98% loss in the last 1 month and extending the period to 3 months gives it a 25.20%, and is 1.58% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.67% over the week and 7.10% over the month.
AnaptysBio Inc (ANAB) has around 136 employees, a market worth around $697.79M and $111.87M in sales. Profit margin for the company is -125.70%. Distance from 52-week low is 94.51% and -42.51% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.20%).
The EPS is expected to shrink by -2.88% this year
The shares outstanding are 30.39M, and float is at 26.44M with Short Float at 34.62%.
The top institutional shareholder in the company is ECOR1 CAPITAL, LLC with over 7.52 million shares valued at $188.48 million. The investor’s holdings represent 27.4931 of the ANAB Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 2.87 million shares valued at $71.94 million to account for 10.4936 of the shares outstanding. The other top investors are FRAZIER LIFE SCIENCES MANAGEMENT, L.P. which holds 2.17 million shares representing 7.9163 and valued at over $54.27 million, while BLACKROCK INC. holds 6.47 of the shares totaling 1.77 million with a market value of $44.35 million.
AnaptysBio Inc (ANAB) Insider Activity
The most recent transaction is an insider sale by RENTON HOLLINGS, the company’s Director. SEC filings show that RENTON HOLLINGS sold 20,925 shares of the company’s common stock on Jul 02 ’25 at a price of $23.57 per share for a total of $0.49 million. Following the sale, the insider now owns 4965.0 shares.
Still, SEC filings show that on Jun 18 ’25, FENTON DENNIS M (Director) disposed off 3,015 shares at an average price of $23.97 for $72270.0. The insider now directly holds 4,965 shares of AnaptysBio Inc (ANAB).
